Innovus Pharmaceuticals Inc (INNV) financial statements (2021 and earlier)

Company profile

Business Address 8845 REHCO ROAD
SAN DIEGO, CA 92121
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,2481,5658305673318
Cash and cash equivalents1,2481,5658305673318
Receivables282683483192217 
Inventory, net of allowances, customer advances and progress billings2,3701,726600254266178
Inventory2,3701,726600254266178 
Prepaid expense1,116363864535535
Deposits current assets     21 
Other undisclosed current assets   98   
Total current assets:5,0163,7222,32754452048418
Noncurrent Assets
Property, plant and equipment2476230355579 
Intangible assets, net (including goodwill)4,8435,2265,8565,8501,4851,295
Goodwill953953953549429421 
Intangible assets, net (excluding goodwill)3,8904,2734,9035,3011,055874 
Deposits noncurrent assets 2115152222 
Other undisclosed noncurrent assets21    233 
Total noncurrent assets:5,1115,3095,9005,9001,5611,629 
TOTAL ASSETS:10,1279,0318,2276,4452,0812,11318
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,6223,4281,463986959  
Accounts payable1,8452,306647    
Accrued liabilities237      
Employee-related liabilities 1,118768907907  
Interest and dividends payable 4487953  
Other undisclosed accounts payable and accrued liabilities540      
Debt3,3391,305627304314370213
Contract with customer, liability108
Other undisclosed current liabilities1,2844131,9421,440(520)71818
Total current liabilities:7,3535,1464,0312,7297541,088231
Noncurrent Liabilities
Long-term debt and lease obligation  552524511 
Long-term debt, excluding current maturities  552524511 
Liabilities, other than long-term debt1,437      
Deferred rent credit181
Business combination, contingent consideration, liability1,256    
Other undisclosed noncurrent liabilities1,2282,9823,0484,1371,729572 
Total noncurrent liabilities:2,6652,9823,1024,1621,7531,083 
Total liabilities:10,0188,1287,1336,8912,5072,172231
Stockholders' equity
Stockholders' equity attributable to parent, including:1099031,094(446)(426)148(212)
Common stock216712247272216
Additional paid in capital43,96736,37530,10814,94110,7796,5312,220
Accumulated deficit(43,860)(35,640)(29,136)(15,435)(11,232)  
Other undisclosed stockholders' equity attributable to parent     (6,405)(2,449)
Other undisclosed stockholders' equity     (206) 
Total stockholders' equity:1099031,094(446)(426)(58)(212)
TOTAL LIABILITIES AND EQUITY:10,1279,0318,2276,4452,0812,11318

Income statement (P&L) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues23,9908,8164,8197361,0307 
Revenue, net8,8064,8187316557 
Cost of revenue(4,325) (1,270) (395)(2) 
Cost of goods and services sold    (292)(2) 
Amortization of value of business acquired (voba)  (1,270) (103)  
Gross profit:19,6658,8163,5497366355 
Operating expenses(25,357)(13,916)(10,653)(5,010)(4,815)(3,894)(219)
Other operating income (expense), net
(Other Expenses)
 (7)2(8)  17
Other undisclosed operating income 71,2688   
Operating loss:(5,692)(5,099)(5,834)(4,275)(4,180)(3,889)(202)
Nonoperating income (expense)(2,587)(1,402)(7,865)(685) 98 
Debt instrument, convertible, beneficial conversion feature     98 
Other nonoperating expense(13)(1,402)(7,865)(685)   
Interest and debt expense(1,332)(700)(6,662)(33)(939)(8)(17)
Other undisclosed income from continuing operations before equity method investments, income taxes 7006,66233   
Loss from continuing operations before equity method investments, income taxes:(9,611)(6,501)(13,699)(4,960)(5,119)(3,799)(219)
Other undisclosed income (loss) from continuing operations before income taxes1,332     (17)
Loss from continuing operations before income taxes:(8,279)(6,501)(13,699)(4,960)(5,119)(3,799)(237)
Income tax expense (benefit)(1,965)(3)(2)757   
Loss before gain (loss) on sale of properties:(10,244)(6,504)(13,701)(4,203)(5,119)(3,799)(237)
Other undisclosed net income (loss)    325(158) 
Net loss:(10,244)(6,504)(13,701)(4,203)(4,794)(3,956)(237)
Other undisclosed net income (loss) attributable to parent1,965   (33)  
Net loss available to common stockholders, diluted:(8,279)(6,504)(13,701)(4,203)(4,827)(3,956)(237)

Comprehensive Income ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(10,244)(6,504)(13,701)(4,203)(4,794)(3,956)(237)
Comprehensive loss, net of tax, attributable to parent:(10,244)(6,504)(13,701)(4,203)(4,794)(3,956)(237)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: